Lexeo Therapeutics, Inc.

14.85 USD
-0.02 (-0.13%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Lexeo Therapeutics, Inc. stock is down -11.66% since 30 days ago. The next earnings date is May 21, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 100% of the previous 1 March’s closed higher than February.

About Lexeo Therapeutics, Inc.

We are a clinical stage genetic medicine company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Our principal executive offices are located at 345 Park Avenue South, Floor 6, New York, New York.